XML 26 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
Note 11 - Goodwill and Intangible Assets
9 Months Ended
Sep. 30, 2022
Notes to Financial Statements  
Goodwill Disclosure [Text Block]

NOTE 11 – Goodwill and Intangible Assets:

 

Goodwill

 

Beginning with the second quarter of fiscal 2022, the Company realigned its reportable segments to Branded Products, Healthcare Apparel and Contact Centers. Refer to Note 10 for further information on the Company’s reportable segments. As a result of this re-segmentation, and in accordance with ASC 350, the Company performed a quantitative goodwill impairment test.

 

During the third quarter of fiscal 2022, the Company determined that a triggering event occurred in relation to the depressed market price of the Company's common stock and corresponding significant decline in the Company’s market capitalization. As a result, the Company performed a quantitative goodwill impairment test.

 

The fair value of goodwill in each impairment test was determined using a combination of an income approach, which estimates fair value based upon projections of future revenues, expenses, and cash flows discounted to their respective present values, and a market approach. The valuation methodology and underlying financial information included in the Company’s determination of fair value required significant judgments by management. The principal assumptions used in the Company’s discounted cash flow analysis consisted of (a) long-term projections of financial performance and (b) the weighted-average cost of capital of market participants, adjusted for the risk attributable to the Company and the industry in which it operates. Under the market approach, the principal assumption included an estimate of a control premium.

 

Based on the goodwill impairment analysis performed, the Company determined that the estimated fair values of the previous Uniforms and Related Products segment and current Branded Products segment were lower than their carrying value primarily as the result of current market conditions, decline in expected cash flows and/or decrease in the Company’s stock price. Consequently, the Company recorded a non-cash goodwill impairment charge of $21.5 million and $45.9 million during the three and nine months ended September 30, 2022, respectively. 

 

We have reclassified prior period goodwill disclosures to conform to the current period presentation. The following table presents the carrying amounts of goodwill attributable to each of the Company’s reportable segments (dollars in thousands):

 

  

Branded Products

  

Healthcare Apparel

  

Total

 

As of December 31, 2021:

            

Gross goodwill

 $19,111  $20,323  $39,434 

Accumulated impairment losses

  -   -   - 

Net goodwill

 $19,111  $20,323  $39,434 
             

Additions

 $6,463  $-  $6,463 

Impairment charge

  (25,595)  (20,323)  (45,918)

Foreign currency translation

  21   -   21 

Net goodwill, September 30, 2022

 $-  $-  $- 
             

As of September 30, 2022:

            

Gross goodwill

 $25,595  $20,323  $45,918 

Accumulated impairment losses

  (25,595)  (20,323)  (45,918)

Net goodwill

 $-  $-  $- 

 

Intangible Assets

 

In conjunction with the Company’s realignment of its reportable segments during the second quarter of 2022, the Company began an effort to centralize certain branding and go-to-market strategies under the BAMKO brand and determined that it would no longer use certain trade names associated with branded products. The Company’s rebranding efforts resulted in a $5.6 million impairment of indefinite-lived trade names related to its Branded Products segment during the nine months ended September 30, 2022. The carrying amounts of indefinite-lived trade names as of September 30, 2022 and December 31, 2021 are summarized as follows (dollars in thousands):

 

Indefinite-lived Intangible Assets

 

Segment

  Carrying Amount, December 31, 2021   Impairment Charges   Carrying Amount, September 30, 2022 

Trade names:

              

HPI

 

Branded Products

 $4,700  $-  $4,700 

BAMKO

 

Branded Products

  8,900   -   8,900 

Public Identity

 

Branded Products

  470   (470)  - 

Tangerine

 

Branded Products

  3,200   (3,200)  - 

Gifts By Design

 

Branded Products

  1,170   (1,170)  - 

Sutter’s Mill

 

Branded Products

  741   (741)  - 

CID Resources

 

Healthcare Apparel

  14,160   -   14,160 

Total

 $33,341  $(5,581) $27,760 

 

Intangible assets as of September 30, 2022 and December 31, 2021 are summarized as follows (dollars in thousands):

 

    

September 30, 2022

 

December 31, 2021

 

Item

Weighted Average Life (In years)

 

Gross Carrying Amount

 

Accumulated Amortization

 

Gross Carrying Amount

 

Accumulated Amortization

 

Definite-lived intangible assets:

               

Customer relationships (7-15 year life)

 11.7 $50,198 $(22,114)$45,198 $(18,772)

Non-compete agreements (3-7 year life)

 5.4  1,712  (1,303) 1,536  (1,121)

Trademarks

 10.0  332  (57) 275  (37)

Trade names

 2.0  710  (148) -  - 

Total

   $52,952 $(23,622)$47,009 $(19,930)
                

Indefinite-lived intangible assets:

               

Trade names

   $27,760    $33,341    
                

Total intangible assets

   $80,712 $(23,622)$80,350 $(19,930)